olczyk eventually made it to 14 games this season, about a third his usual workload, each one a welcome escape..

loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people..

why novartis� landmark cancer drug approval is great news for bluebird..

china is host to 70 percent of all car cell therapy trials registered in 2017 and the first four months of 2018 (150 out of 214)..

home